Mirae Asset Global Investments’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $68.2K | Buy |
11,895
+1,614
| +16% | +$9.25K | ﹤0.01% | 1210 |
|
|
2025
Q1 | $86.7K | Buy |
10,281
+324
| +3% | +$2.73K | ﹤0.01% | 1141 |
|
|
2024
Q4 | $95.9K | Sell |
9,957
-770
| -7% | -$7.42K | ﹤0.01% | 1153 |
|
|
2024
Q3 | $115K | Buy |
10,727
+1,884
| +21% | +$20.2K | ﹤0.01% | 1164 |
|
|
2024
Q2 | $87.6K | Sell |
8,843
-203,042
| -96% | -$2.01M | ﹤0.01% | 1157 |
|
|
2024
Q1 | $2.39M | Sell |
211,885
-17,719
| -8% | -$200K | 0.01% | 1112 |
|
|
2023
Q4 | $3.26M | Buy |
229,604
+19,204
| +9% | +$273K | 0.01% | 1052 |
|
|
2023
Q3 | $2.56M | Sell |
210,400
-8,737
| -4% | -$106K | 0.01% | 1085 |
|
|
2023
Q2 | $2.75M | Buy |
219,137
+9,088
| +4% | +$114K | 0.01% | 1064 |
|
|
2023
Q1 | $2.33M | Buy |
210,049
+23,937
| +13% | +$265K | 0.01% | 1142 |
|
|
2022
Q4 | $2.27M | Sell |
186,112
-5,276
| -3% | -$64.4K | 0.01% | 1087 |
|
|
2022
Q3 | $2M | Buy |
191,388
+16,040
| +9% | +$167K | 0.01% | 1137 |
|
|
2022
Q2 | $1.88M | Buy |
+175,348
| New | +$1.88M | ﹤0.01% | 1155 |
|
|
2021
Q2 | – | Sell |
-94,611
| Closed | -$935K | – | 1707 |
|
|
2021
Q1 | $935K | Buy |
94,611
+39,643
| +72% | +$392K | ﹤0.01% | 1148 |
|
|
2020
Q4 | $1.27M | Sell |
54,968
-20,900
| -28% | -$483K | ﹤0.01% | 1070 |
|
|
2020
Q3 | $1.07M | Buy |
+75,868
| New | +$1.07M | 0.01% | 947 |
|
|
2020
Q1 | – | Sell |
-106,898
| Closed | -$1.04M | – | 1441 |
|
|
2019
Q4 | $1.04M | Buy |
106,898
+9,007
| +9% | +$87.7K | 0.01% | 951 |
|
|
2019
Q3 | $785K | Buy |
+97,891
| New | +$785K | 0.01% | 993 |
|